Edgewise Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:EWTX

Comments

Edgewise Therapeutics Inc Earnings Estimates

EWTXNASDAQ

Trade with Public

$29.59

-0.35-1.17%

At close: Mar 13, 5:00 PM EST

$29.59

N/A

After Hours: 4:00 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Edgewise Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:EWTX

Edgewise Therapeutics (EWTX) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.49 and quarterly revenue of N/A.

In the most recent quarter (Q4), Edgewise Therapeutics reported EPS of $-0.47, missing estimates of $-0.44 by 0.07%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Edgewise Therapeutics has averaged an EPS surprise of 0.11% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-0.490

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Edgewise Therapeutics Earnings History

Analyze the earnings history of Edgewise Therapeutics using advanced sorting and filters.

Loading calendar...

Edgewise Therapeutics (EWTX) Earnings Per Share

The chart below shows Edgewise Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Edgewise Therapeutics (EWTX) Revenue

The chart below shows Edgewise Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Edgewise Therapeutics (NASDAQ:EWTX) reporting earnings?

Edgewise Therapeutics (EWTX) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on February 26, 2026 for Q4.

What were the latest earnings per share (EPS) for Edgewise Therapeutics (NASDAQ:EWTX)?

The Actual EPS was $-0.47, which missed the estimate of $-0.44.

What were Edgewise Therapeutics’s (NASDAQ:EWTX) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Supernus Pharmaceuticals Inc

NASDAQ:SUPN

$49.91

WAVE Life Sciences Ltd

NASDAQ:WVE

$12.89

-1.00%

Tarsus Pharmaceuticals Inc

NASDAQ:TARS

$67.96

Phibro Animal Health Corp

NASDAQ:PAHC

$49.47

Terns Pharmaceuticals Inc

NASDAQ:TERN

$47.00

1.03%

Axsome Therapeutics Inc

Ocular Therapeutix Inc

NASDAQ:OCUL

$8.70

-0.68%

Edgewise Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:EWTX

Edgewise Therapeutics (EWTX) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.49 and quarterly revenue of N/A.

In the most recent quarter (Q4), Edgewise Therapeutics reported EPS of $-0.47, missing estimates of $-0.44 by 0.07%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Edgewise Therapeutics has averaged an EPS surprise of 0.11% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-0.490

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–